Brain science pioneer shifts focus of NIMH to basic neuroscience and genetics

| February 6, 2014
INSE master
Lexey Swall for The New York Times
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The New York Times profiles brain science pioneer, Dr. Thomas R. Insel director of the National Institute of Mental Health. As director he has “sharply shifted the agency’s focus — to basic neuroscience and genetics, at the expense of the very type of behavioral research he himself had once done. That change has generated a mix of optimism and outrage.”

[Dr. Insel has a] stubborn conviction is that the only way to build a real psychiatric science is from first principles — from genes and brain biology, as opposed to identifying symptom clusters. Some of the mental health institute’s largest outlays under Dr. Insel have been to support projects that, biologically speaking, are like mapping the ocean floor.

One is the Psychiatric Genomics Consortium, a far-flung group of top research centers that share data and analysis, based at the lab of Dr. Patrick F. Sullivan at the University of North Carolina. The other is the Human Connectome Project, a $40 million, five-year program to build a baseline database for brain structure and activity using M.R.I. imaging.

Read the full, original article: Blazing Trails in Brain Science



The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend